We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,280 results
  1. Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions

    Background

    The optimal treatment for multiple brain metastases has been recently controversially discussed.This study was aimed to explore the...

    ** Chen, ... Hui Wang in BMC Cancer
    Article Open access 24 August 2023
  2. Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases

    Background and purpose

    To evaluate the clinical outcomes of hypofractionated stereotactic radiotherapy (HFSRT) combined with whole brain radiotherapy...

    Xue-Yi **e, Hong-Hua Peng, ... Pei-Guo Cao in Radiation Oncology
    Article Open access 26 July 2022
  3. Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center

    Background

    Brain metastases (BM) are a common complication in advanced cancer patients, and extremely challenging to treat. Consequently, whole brain...

    Bolanle Adegboyega, Adedayo Joseph, ... Wilfred Ngwa in BMC Cancer
    Article Open access 14 December 2023
  4. May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy?

    Purpose

    One of the main limiting factors of whole-brain radiation therapy (WBRT) for primary central nervous system lymphoma (PCNSL) is the impairment...

    Ciro Mazzarella, Silvia Chiesa, ... Mario Balducci in Radiation Oncology
    Article Open access 02 October 2023
  5. Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy

    The prognosis and prognostic factors of patients receiving whole-brain radiotherapy (WBRT) for leptomeningeal metastasis (LM) from lung...

    Hidekazu Oyoshi, Hidenari Hirata, ... Tetsuo Akimoto in Clinical & Experimental Metastasis
    Article 19 July 2023
  6. “sCT-Feasibility” - a feasibility study for deep learning-based MRI-only brain radiotherapy

    Background

    Radiotherapy (RT) is an important treatment modality for patients with brain malignancies. Traditionally, computed tomography (CT) images...

    Johanna Grigo, Juliane Szkitsak, ... Christoph Bert in Radiation Oncology
    Article Open access 08 March 2024
  7. Application of piecewise VMAT technique to whole-brain radiotherapy with simultaneous integrated boost for multiple metastases

    Purpose

    This study implemented a piecewise volumetric modulated arc therapy (P-VMAT) for realizing whole-brain radiation therapy (WBRT) with...

    Yuan Xu, Yingjie Xu, ... Jianrong Dai in Radiation Oncology
    Article Open access 07 May 2022
  8. Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases

    Background

    Brain metastases (BMs) are the most frequent intracranial tumours associated with poor clinical outcomes. Radiotherapy is essential in the...

    Kunning Zhang, Tian Zhang, ... ** Wang in BMC Cancer
    Article Open access 16 December 2023
  9. Neurocognition and mean radiotherapy dose to vulnerable brain structures: new organs at risk?

    Background

    Children with brain tumors are at high risk of neurocognitive decline after radiotherapy (RT). However, there is a lack of studies on how...

    Helena Söderström, Angelica Walfridsson, ... Gustaf Ljungman in Radiation Oncology
    Article Open access 11 August 2023
  10. Analysis of the efficacy of upfront brain radiotherapy versus deferred radiotherapy for EGFR/ALK-positive non-small cell lung cancer with brain metastases: a retrospective study

    Background

    For brain metastases (BMs) from EGFR/ALK -positive non-small cell lung cancer (NSCLC), the best time to administer tyrosine kinase...

    **g Qian, Zelai He, ... **anming Li in BMC Cancer
    Article Open access 23 January 2024
  11. Fractionated stereotactic radiotherapy of brain metastases: results of a retrospective study

    Background

    Lasting local control of brain metastases following stereotactic radiotherapy is becoming increasingly relevant since systemic treatment...

    Isabella Gruber, Philipp Stark, ... Oliver Koelbl in Radiation Oncology
    Article Open access 22 May 2023
  12. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization

    Background

    Brain metastasis is one of the main causes of recurrence and death in non-small cell lung cancer (NSCLC). Although radiotherapy is the main...

    Lichao Liu, Jian Wang, ... **aorong Dong in Journal of Experimental & Clinical Cancer Research
    Article Open access 29 April 2024
  13. Dose-effect relationship of linear accelerator based stereotactic radiotherapy for brain metastases

    Objective

    The purpose of this study is to reveal the dose-effect relationship of linear accelerator (LINAC)-based stereotactic radiotherapy (SRT) in...

    Ning Wu, Zhiqiang Wang, ... Hongfu Zhao in Radiation Oncology
    Article Open access 30 October 2023
  14. Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases

    Background

    The main challenge in follow-up duration of patients with brain metastases after stereotactic radiotherapy is to distinguish between...

    Siran Yang, Yuchao Ma, ... Hongmei Zhang in Radiation Oncology
    Article Open access 14 February 2023
  15. Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models

    Background

    Approximately 20% of all cancer patients will develop brain metastases in their lifespan. The standard of care for patients with multiple...

    K. E. Blethen, S. A. Sprowls, ... P. R. Lockman in Radiation Oncology
    Article Open access 03 February 2023
  16. Glasgow prognostic score for assessing the efficacy of whole-brain radiation therapy in cases of recursive partitioning analysis class 2 and class 3 multiple brain metastases: a retrospective study

    Purpose

    Whole-brain radiotherapy (WBRT) may not be beneficial for patients with brain metastases (BMs). The Glasgow Prognostic Score (GPS) is a...

    Yojiro Ishikawa, Rei Umezawa, ... Keiichi **gu in Acta Neurologica Belgica
    Article Open access 25 September 2023
  17. First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis

    Background

    It remains uncertain whether first-line treatment with upfront brain radiotherapy (RT) in combined with epidermal growth factor receptor...

    Yaowen Song, Shuiyu Lin, ... Jun Dang in BMC Cancer
    Article Open access 30 October 2023
  18. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?

    Background

    Primary central nervous system lymphoma (PCNSL) is a rare and aggressive malignancy. Although potentially curable, its prognosis remains...

    Luís Alberto de Pádua Covas Lage, Vinícius Araújo Soares, ... Juliana Pereira in Radiation Oncology
    Article Open access 22 October 2022
  19. Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases

    Background

    The management of melanoma with brain metastases (MBM) is increasingly complex, especially given recent improvements in targeted agents,...

    Cecilia Jiang, Troy J. Kleber, ... Mohammad K. Khan in Radiation Oncology
    Article Open access 08 February 2021
Did you find what you were looking for? Share feedback.